Scientists identify the mechanisms leading to resistance to lung cancer treatment with Sotorasib

According to recent figures published by the Spanish Society of Medical Oncology (SEOM), more than 30,000 new cases of lung cancer will be diagnosed in Spain in 2023, making it the second most frequent type of cancer in this country. In addition to its high prevalence, its 5-year survival rate is one of the lowest of all cancers. In fact, lung cancer is by far the deadliest cancer—it caused more than 22,000 deaths in 2021.